CTRI/2021/05/033844进行中（未招募）未知
Quantitative Analyses and Prediction of anti-VEGF treatment effectiveness in Diabetic Macular Edema (DME) and neovascular Age related Macular Degeneration (nAMD) with relation to central subfield thickness (CST) and sub retinal fluid volume outcomes, respectively, using machine learning (ML) methods
Carl Zeiss India Bangalore Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Males or females 18 years of age or older
- •2. Patients who underwent OCT examination on CIRRUS HD OCT 5000 and/or Spectralis OCT
- •3. Type I or Type II diabetes with the case of DME in both eyes
- •4. Patients who underwent Anti-VEGF treatment
排除标准
- •1. Subjects less than 18 years of age
- •2. Non-Diabetic subjects
- •3. Subjects with any comorbidities
- •4. Case of macular edema due to causes other than DME
- •5. Patients without follow up data
- •6. Patients with no pre-OCT data
研究者
相似试验
进行中（未招募）
1 期
To Study Aqueous Humor Composition and Retinal Imaging Features in Response to Anti-VEGF in Neovascular Age-Related Macular Degeneration and Diabetic Macular EdemaTreatment Naïve Neovascular Age-Related Macular Degeneration (nAMD) and Treatment Naïve diabetic macular edema (DME)MedDRA version: 20.0Level: SOCClassification code 10015919Term: Eye disordersSystem Organ Class: 10015919 - Eye disordersEUCTR2020-003515-10-PLF. Hoffmann-La Roche Ltd200
进行中（未招募）
1 期
To Study Aqueous Humor Composition and Retinal Imaging Features in Response to Anti-VEGF in Neovascular Age-Related Macular Degeneration and Diabetic Macular EdemaEUCTR2020-003515-10-ITF. HOFFMANN - LA ROCHE LTD.200
进行中（未招募）
1 期
To Study Aqueous Humor Composition and Retinal Imaging Features in Response to Anti-VEGF in Neovascular Age-Related Macular Degeneration and Diabetic Macular EdemaTreatment Naïve Neovascular Age-Related Macular Degeneration (nAMD) and Treatment Naïve diabetic macular edema (DME)MedDRA version: 20.0Level: SOCClassification code 10015919Term: Eye disordersSystem Organ Class: 10015919 - Eye disordersEUCTR2020-003515-10-CZF. Hoffmann-La Roche Ltd200
尚未招募
不适用
Evaluation of the responsiveness of anti-VEGF treatment in DMEdiabetic retinopathy (DR)NL-OMON29053GSMS70
已完成
不适用
Clinical study in new protocol of anti-VEGF agents for macular edema with retinal vein occlusion and in relation between the protocol and cytokinesRetinal Vein OcclusionJPRN-UMIN000030311Tokyo medical university100